Australia's Medical Research Sector Faces Funding Crisis Amidst MRFF Surplus
Australia's medical research sector is grappling with significant funding challenges, leading to warnings from researchers about job insecurity and a decline in the workforce. This situation persists despite the Medical Research Future Fund (MRFF) holding capital that now exceeds its original target.
Concerns center on low grant success rates and a government-imposed cap on annual disbursements from the MRFF, which has led to calls for increased spending from the fund.
Deep Dive into Funding Challenges
Professor Andrew Coats, scientific director and chief executive of Australia's Heart Research Institute, has voiced concerns regarding the future of medical research careers in Australia. He attributes these challenges to diminishing success rates for government-funded research grants, which he states are impacting Australia's research output and careers. These issues arise even as the Medical Research Future Fund (MRFF) holds approximately $5 billion above its intended $20 billion baseline.
Declining Grant Success Rates Threaten Workforce
Grant application success rates have been notably low across the sector. Reports indicate that 91.9% to 92% of Australian medical researchers applying for the National Health and Medical Research Council's (NHMRC) annual "ideas grants" were unsuccessful last year, with some rounds reporting a success rate of one in 10.
This challenging environment has been directly linked to growing job insecurity, with some researchers reportedly abandoning their careers entirely. Major grant applications can require three months to prepare, contributing to what is described as wasted effort when the chances of success are so minimal.
The Australian Health and Medical Research Workforce Audit indicates that over 60% of researchers left active roles between 2019 and 2024. Concrete examples highlight this trend:
- Dr. Rehan Villani left skin cancer research due to funding difficulties and high childcare costs before eventually returning to research on inherited diseases.
- Hamish McWilliam, an immunology researcher, moved to the private sector following funding cut-offs.
The Medical Research Future Fund (MRFF): A Growing Surplus with a Cap
The Medical Research Future Fund (MRFF), established in 2015, was originally designed to disburse $1 billion annually for medical research once it reached a $20 billion valuation. The fund achieved this target in 2020 and has since grown to over $25 billion, surpassing its original benchmark.
However, in 2022, the Morrison government introduced a spending cap, limiting annual disbursements to $650 million until 2032-33.
This cap has resulted in nearly $1 billion less being spent on research since 2022 than originally anticipated under the original disbursement goal. Proponents of the cap argue that it promotes sustainable growth and isolates disbursements from market fluctuations.
Widespread Calls for Increased MRFF Disbursements
The research sector, including federal crossbench MPs, universities, and major groups such as the Group of Eight universities, the Association of Australian Medical Research Institutes (AAMRI), and the Australian Academy of Health and Medical Sciences, strongly advocates for the Albanese government to increase annual disbursements from the MRFF.
Parliamentary Budget Office costings, commissioned by independent MP Monique Ryan, suggest that annual disbursements could be raised to $1.4 billion without affecting a $24.5 billion base level over the next decade.
Professor Grant Ramm, chief scientist at the Queensland Institute of Medical Research (QIMR), described the current funding environment as significantly challenging for Australian medical research. Nadia Levin, chief executive of Research Australia, emphasized that chronic underfunding can undermine workforce stability, lead talented researchers to leave, and constrain the country's overall research capacity.
Government Responds to Sector's Concerns
Health Minister Mark Butler acknowledged the calls from the sector for larger disbursements from the accrued capital fund. He stated that the health and medical research budget has grown significantly over the past 15 years and confirmed that the government is currently reviewing a report submitted last year concerning these issues.